At 1 or 3 weeks post-kaolin injection (10 kaolin and 5 control at each time point), rats were imaged with a volume coil 32 mm diameter and the following parameters: six slices 1 mm thickness with interslice gap of 1 mm; in-plane voxel resolution 0.117 mm × 0.117 mm; recovery time 600 ms; echo time 13 ms. Following anesthesia, a 30-gauge tail vein cannula was placed.
Prior to the MRI examinations, animals were anesthetized by intraperitoneal injections of ketamine (100 mg/kg body weight) and xylazine (10 mg/kg body weight) followed by the insertion of a 25-gauge butterfly tail vein catheter for administration of contrast agent.
Likewise, it was hard to gauge the exposures to "tail" risks built up by sellers of swaps on CDOs such as AIG and bond insurers.
Rats were ventilated, and a 3-F catheter was placed in the jugular (n = 1) or a 24-gauge catheter in the tail (n = 4) vein.
Approximately 500 μl blood was aspirated with a 27-gauge needle from the tail vein of the rats.
Like our own heart beat, a shark's tail 'beat' can gauge how the shark is doing while being worked up.
Whole blood was collected via pipette directly from a 26 gauge catheter placed in the tail vein of anaesthetized rats.
Rats were injected with 18 81 MBq of [18F]FPYKYNE-losartan (<1 ml volume) via a 26-gauge catheter into the lateral tail vein.
Each bolus injection of SonoVue was through a 27-gauge needle mounted to the tail vein, followed by a 0.2 mL saline flush.
A volume of 10 to 40 μL of 645 µM of ICG (IC-Green, Akorn, Inc., Buffalo Grove, IL) or 10 μl of EBD (5mg/ml; Sigma, St . Louis MO) reconstituted in USP standard 0.9% Sodium Chloride (Hospira, Inc., Lake Forest, IL) was injected intradermally into the base of each mouse tail with 31-gauge needles (BD Ultra-FineTM II Short Needle, Becton and Dickinson Medical, Franklin, NJ).
